Outlook Therapeutics, Inc. (OTLK) › Shareholders' EquityOutlook Therapeutics, Inc. (OTLK) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2015: -$54.22M2016: -$5.17M2017: -$33.65M2018: -$25.54M2019: -$16.13M2020: $2.83M2021: $4.61M2022: $8.74M2023: -$14.44M2024: -$73.08M2025: -$32.19M-$32.19M2015Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025-$32.19M+56.0%2024-$73.08M-406.1%2023-$14.44M-265.3%2022$8.74M+89.6%2021$4.61M+63.0%2020$2.83M+117.5%2019-$16.13M+36.9%2018-$25.54M+24.1%2017-$33.65M-550.5%2016-$5.17M+90.5%2015-$54.22M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share